Melatonin Orifarm

Melatonin, the active ingredient in Melatonin Orifarm, is a melatonin receptor agonist presented as an oral tablet for oral use. It helps regulate the sleep‑wake cycle and is used to manage insomnia, jet lag and other circadian rhythm sleep disorders in adults across European markets.

GNH USA supplies Melatonin Orifarm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing for global healthcare providers.

Melatonin Orifarm is a melatonin receptor agonist used to treat sleep‑related conditions by influencing the body's circadian rhythm.

Insomnia: reduces sleep onset latency and improves sleep continuity in adults. Jet lag: helps synchronize the internal clock after rapid time‑zone travel, facilitating faster adaptation. Circadian rhythm sleep disorders: supports normalization of disrupted sleep‑wake patterns such as shift‑work disorder.

Melatonin Orifarm may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Headache - Dizziness - Nausea - Daytime sleepiness - Vivid dreams - Mild gastrointestinal discomfort

Serious or Rare Side Effects: - Allergic reaction (rash, swelling, itching) - Severe dizziness or vertigo - Mood changes including depression or anxiety - Abnormal heart rhythm (arrhythmia) - Hallucinations or confusion - Severe hypotension

When considering Melatonin Orifarm, several precautionary measures should be observed to ensure safe use.

Confirm diagnosis: verify that the sleep disturbance is appropriate for melatonin therapy. Avoid concurrent CNS depressants: limit use with alcohol, benzodiazepines or other sedatives. Hepatic impairment: use with caution in patients with liver disease, as metabolism may be altered. Pediatric use: not recommended for children unless specifically prescribed by a qualified clinician. Operating machinery: refrain from driving or operating heavy equipment until individual response is known. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Melatonin Orifarm can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Benzodiazepines or other central nervous system depressants: additive sedative effect may impair alertness. - Anticoagulants such as warfarin: melatonin may enhance anticoagulant activity and increase bleeding risk. - Monoamine oxidase inhibitors (MAOIs): potential for exaggerated serotonergic effects.

Moderate Interactions (Monitor Closely): - Oral contraceptives: melatonin may reduce contraceptive effectiveness. - Antihypertensive agents: possible additive blood‑pressure‑lowering effect. - Caffeine‑containing products: may counteract melatonin’s sleep‑promoting action. - Antiepileptic drugs: may alter melatonin plasma levels, affecting seizure control.